Patient Care and Research

AUA/ASCO/ASTRO/SUO Guideline on Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer

Published: April 2017

Read Executive Summary
Read Full-Text Guideline

This multisociety guideline addresses four topics related to the treatment of muscle-invasive bladder cancer that has not metastasized. 1) initial patient evaluation and counseling; 2) recommendations on treatment therapies (neoadjuvant chemotherapy, radical cystectomy, pelvic lymphadectomy and bladder preserving approaches). 3) patient surveillance, follow-up and survivorship; and 4) the role of variant histology for management of urothelial carcinoma.

Developed in collaboration with:

  • American Urological Association
  • American Society of Clinical Oncology
  • American Society for Radiation Oncology
  • Society of Urologic Oncology

Key Points:

  • Initial patient evaluation and counseling
  • Patient surveillance and follow up
  • Bladder preservation


Muscle Invasive Bladder Cancer Algorithum
Patient Brochure


We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.